These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27501362)

  • 1. Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes.
    Bender HR; Kane S; Zabel MD
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopeptide Delivery of siRNA to the Central Nervous System.
    Zabel MD; Mollnow L; Bender H
    Methods Mol Biol; 2019; 1943():389-403. PubMed ID: 30838631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures.
    Pulford B; Reim N; Bell A; Veatch J; Forster G; Bender H; Meyerett C; Hafeman S; Michel B; Johnson T; Wyckoff AC; Miele G; Julius C; Kranich J; Schenkel A; Dow S; Zabel MD
    PLoS One; 2010 Jun; 5(6):e11085. PubMed ID: 20559428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System.
    Zabel MD; Mollnow L; Bender H
    Methods Mol Biol; 2021; 2282():377-394. PubMed ID: 33928585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment.
    Bender H; Noyes N; Annis JL; Hitpas A; Mollnow L; Croak K; Kane S; Wagner K; Dow S; Zabel M
    PLoS One; 2019; 14(7):e0219995. PubMed ID: 31329627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvascular delivery of small interfering RNA to the central nervous system.
    Kumar P; Wu H; McBride JL; Jung KE; Kim MH; Davidson BL; Lee SK; Shankar P; Manjunath N
    Nature; 2007 Jul; 448(7149):39-43. PubMed ID: 17572664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery.
    Podesta JE; Kostarelos K
    Methods Enzymol; 2009; 464():343-54. PubMed ID: 19903563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anionic amino acid-derived cationic lipid for siRNA delivery.
    Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
    J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
    Yao Y; Su Z; Liang Y; Zhang N
    Int J Nanomedicine; 2015; 10():6185-97. PubMed ID: 26491291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
    Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
    AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopeptide delivery of siRNA to the central nervous system.
    Zabel MD
    Methods Mol Biol; 2013; 948():251-62. PubMed ID: 23070775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
    Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
    Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer.
    Jose A; Labala S; Venuganti VV
    J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.
    Hattori Y; Arai S; Kikuchi T; Ozaki KI; Kawano K; Yonemochi E
    J Drug Target; 2016 Apr; 24(4):309-317. PubMed ID: 26234899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery.
    Tagalakis AD; Lee DH; Bienemann AS; Zhou H; Munye MM; Saraiva L; McCarthy D; Du Z; Vink CA; Maeshima R; White EA; Gustafsson K; Hart SL
    Biomaterials; 2014 Sep; 35(29):8406-15. PubMed ID: 24985735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes.
    Buyens K; Demeester J; De Smedt SS; Sanders NN
    Langmuir; 2009 May; 25(9):4886-91. PubMed ID: 19341292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
    Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
    Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.